These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer. Marín-Aguilera M; Jiménez N; Reig Ò; Montalbo R; Verma AK; Castellano G; Mengual L; Victoria I; Pereira MV; Milà-Guasch M; García-Recio S; Benítez-Ribas D; Cabezón R; González A; Juan M; Prat A; Mellado B Cells; 2020 Jan; 9(1):. PubMed ID: 31947623 [TBL] [Abstract][Full Text] [Related]
3. Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer Patients. Danila DC; Samoila A; Patel C; Schreiber N; Herkal A; Anand A; Bastos D; Heller G; Fleisher M; Scher HI Cancer J; 2016; 22(5):315-320. PubMed ID: 27749322 [TBL] [Abstract][Full Text] [Related]
4. Prognosis of Castration-resistant Prostate Cancer Patients - Use of the AdnaTest® System for Detection of Circulating Tumor Cells. Čapoun O; Mikulová V; Jančíková M; Honová H; Kološtová K; Sobotka R; Michael P; Zima T; Hanuš T; Soukup V Anticancer Res; 2016 Apr; 36(4):2019-26. PubMed ID: 27069196 [TBL] [Abstract][Full Text] [Related]
5. Detecting androgen receptor (AR), AR variant 7 (AR-V7), prostate-specific membrane antigen (PSMA), and prostate-specific antigen (PSA) gene expression in CTCs and plasma exosome-derived cfRNA in patients with metastatic castration-resistant prostate cancer (mCRPC) by integrating the VTX-1 CTC isolation system with the QIAGEN AdnaTest. Liu HE; Vuppalapaty M; Hoerner CR; Bergstrom CP; Chiu M; Lemaire C; Che J; Kaur A; Dimmick A; Liu S; Metzner TJ; Araya M; Crouse S; Sprenger-Haussels M; Schlumpberger M; Leppert JT; Hauch S; Sollier E; Fan AC BMC Cancer; 2024 Apr; 24(1):482. PubMed ID: 38627648 [TBL] [Abstract][Full Text] [Related]
6. Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer. Sharp A; Welti JC; Lambros MBK; Dolling D; Rodrigues DN; Pope L; Aversa C; Figueiredo I; Fraser J; Ahmad Z; Lu C; Rescigno P; Kolinsky M; Bertan C; Seed G; Riisnaes R; Miranda S; Crespo M; Pereira R; Ferreira A; Fowler G; Ebbs B; Flohr P; Neeb A; Bianchini D; Petremolo A; Sumanasuriya S; Paschalis A; Mateo J; Tunariu N; Yuan W; Carreira S; Plymate SR; Luo J; de Bono JS Eur Urol; 2019 Nov; 76(5):676-685. PubMed ID: 31036442 [TBL] [Abstract][Full Text] [Related]
7. Standardization of CTC AR-V7 PCR assay and evaluation of its role in castration resistant prostate cancer progression. Tommasi S; Pilato B; Carella C; Lasorella A; Danza K; Vallini I; De Summa S; Naglieri E Prostate; 2019 Jan; 79(1):54-61. PubMed ID: 30141201 [TBL] [Abstract][Full Text] [Related]
8. Expression of tumour progression-associated genes in circulating tumour cells of patients at different stages of prostate cancer. Russo GI; Bier S; Hennenlotter J; Beger G; Pavlenco L; van de Flierdt J; Hauch S; Maas M; Walz S; Rausch S; Bedke J; Morgia G; Stenzl A; Todenhöfer T BJU Int; 2018 Jul; 122(1):152-159. PubMed ID: 29542849 [TBL] [Abstract][Full Text] [Related]
9. Detection of Androgen Receptor Variant 7 ( Hille C; Gorges TM; Riethdorf S; Mazel M; Steuber T; Amsberg GV; König F; Peine S; Alix-Panabières C; Pantel K Cells; 2019 Sep; 8(9):. PubMed ID: 31514447 [TBL] [Abstract][Full Text] [Related]
10. Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275). Francolini G; Loi M; Ciccone LP; Detti B; Di Cataldo V; Pinzani P; Salvianti F; Salvatore G; Sottili M; Santini C; Frosini G; Visani L; Burchini L; Mattioli C; Allegra AG; Valzano M; Cerbai C; Aquilano M; Salvestrini V; Desideri I; Mangoni M; Meattini I; Livi L Med Oncol; 2022 Jun; 39(8):119. PubMed ID: 35687207 [TBL] [Abstract][Full Text] [Related]
11. Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275). Francolini G; Loi M; Salvestrini V; Mangoni M; Detti B; Di Cataldo V; Aquilano M; Pinzani P; Salvianti F; Desideri I; Mariotti M; Garlatti P; Stocchi G; Ciccone LP; Lucidi S; Salvatore G; Sottili M; Meattini I; Livi L Clin Exp Metastasis; 2021 Oct; 38(5):451-458. PubMed ID: 34410545 [TBL] [Abstract][Full Text] [Related]
12. Expression pattern of androgen receptors, AR-V7 and AR-567es, in circulating tumor cells and paired plasma-derived extracellular vesicles in metastatic castration resistant prostate cancer. Strati A; Zavridou M; Bournakis E; Mastoraki S; Lianidou E Analyst; 2019 Nov; 144(22):6671-6680. PubMed ID: 31596277 [TBL] [Abstract][Full Text] [Related]
13. ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer. Cato L; de Tribolet-Hardy J; Lee I; Rottenberg JT; Coleman I; Melchers D; Houtman R; Xiao T; Li W; Uo T; Sun S; Kuznik NC; Göppert B; Ozgun F; van Royen ME; Houtsmuller AB; Vadhi R; Rao PK; Li L; Balk SP; Den RB; Trock BJ; Karnes RJ; Jenkins RB; Klein EA; Davicioni E; Gruhl FJ; Long HW; Liu XS; Cato ACB; Lack NA; Nelson PS; Plymate SR; Groner AC; Brown M Cancer Cell; 2019 Mar; 35(3):401-413.e6. PubMed ID: 30773341 [TBL] [Abstract][Full Text] [Related]
14. Droplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood Biopsies. Ma Y; Luk A; Young FP; Lynch D; Chua W; Balakrishnar B; de Souza P; Becker TM Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527157 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of cabazitaxel and androgen splicing variant-7 status in circulating tumor cells in Asian patients with metastatic castration-resistant prostate cancer. Ashizawa T; Nagata M; Nakamura S; Hirano H; Nagaya N; Lu Y; Horie S Sci Rep; 2022 Oct; 12(1):18016. PubMed ID: 36289357 [TBL] [Abstract][Full Text] [Related]
16. Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes. Nimir M; Ma Y; Jeffreys SA; Opperman T; Young F; Khan T; Ding P; Chua W; Balakrishnar B; Cooper A; De Souza P; Becker TM Cells; 2019 Jul; 8(7):. PubMed ID: 31288377 [TBL] [Abstract][Full Text] [Related]
17. Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial). Hench IB; Cathomas R; Costa L; Fischer N; Gillessen S; Hench J; Hermanns T; Kremer E; Mingrone W; Mestre RP; Püschel H; Rothermundt C; Ruiz C; Tolnay M; Burg PV; Bubendorf L; Vlajnic T; Sakk SGFCCR Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31374981 [TBL] [Abstract][Full Text] [Related]
18. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer. Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns. De Laere B; van Dam PJ; Whitington T; Mayrhofer M; Diaz EH; Van den Eynden G; Vandebroek J; Del-Favero J; Van Laere S; Dirix L; Grönberg H; Lindberg J Eur Urol; 2017 Aug; 72(2):192-200. PubMed ID: 28104311 [TBL] [Abstract][Full Text] [Related]
20. Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment. Bredemeier M; Edimiris P; Tewes M; Mach P; Aktas B; Schellbach D; Wagner J; Kimmig R; Kasimir-Bauer S Oncotarget; 2016 Jul; 7(27):41677-41690. PubMed ID: 27223437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]